Hepatoblastoma is the most common primary liver malignancy in infants and young children. It is usually diagnosed before the third year of life and is twice as common in boys than in girls. Most cases are sporadic, but the condition can also be associated with congenital abnormalities such as Beckwith-Wiedemann syndrome, trisomy 18, trisomy 21, Aicardi syndrome, Li-Fraumeni syndrome, and familial adenomatous polyposis. Extremely premature infants with birth weight <1 kg have greatly increased risk of hepatoblastoma development. There have been isolated cases of hepatoblastomas in older children and adults; these tend to have a poorer prognosis.
Hepatoblastomas present as a rapidly growing singular well-circumscribed solid mass. They are more common in the right hepatic lobe. Due to rapid growth, rupture and hemorrhage are potentially deadly complications if unrecognized. Microscopically, these tumors are composed of embryonal and fetal hepatic elements. Prognosis is based on histologic type, with well-differentiated pure tumors having the best prognosis and poorly differentiated small cell tumors having the worst prognosis.
Symptoms include abdominal swelling, abdominal pain, vomiting, poor feeding or feeding intolerance, weight loss, anorexia, and irritability. Serum alpha fetoprotein (AFP) is elevated in 80%-90% of patients. Tumor rupture may present with vomiting, peritonitis, and severe anemia.
Hepatoblastoma
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
C22.2 – Hepatoblastoma
SNOMEDCT:
109843000 – Hepatoblastoma
C22.2 – Hepatoblastoma
SNOMEDCT:
109843000 – Hepatoblastoma
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:05/06/2018
Last Updated:06/26/2022
Last Updated:06/26/2022
Hepatoblastoma